These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35704458)

  • 21. Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence.
    Raisch DW; Fudala PJ; Saxon AJ; Walsh R; Casadonte P; Ling W; Johnson BA; Malkerneker U; Ordorica P; Williford WO; Sather MR
    J Am Pharm Assoc (2003); 2005; 45(1):23-32. PubMed ID: 15730114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial.
    Cochran G; Field C; Karp J; Seybert AL; Chen Q; Ringwald W; Hruschak V; Chickering S; Kincman J; Jaber A; Tarter R
    J Am Pharm Assoc (2003); 2018; 58(4):395-403. PubMed ID: 29691197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.
    Bachyrycz A; Shrestha S; Bleske BE; Tinker D; Bakhireva LN
    Subst Abus; 2017; 38(1):55-60. PubMed ID: 27164192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine opioid outcome monitoring in community pharmacy: Pilot implementation study protocol.
    Nielsen S; Kowalski M; Wood P; Larney S; Bruno R; Shanahan M; Lenton S; Dietze P; Green T; Murnion B; Ritter A
    Res Social Adm Pharm; 2019 Aug; 15(8):1047-1055. PubMed ID: 30396825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improving Community Pharmacist-Delivered Care for Patients With Psychiatric Disorders Filling an Opioid Prescription.
    Werremeyer A; Frenzel O; Strand MA; Eukel H; Skoy E; Steig J
    Psychiatr Serv; 2022 Nov; 73(11):1294-1297. PubMed ID: 35502518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
    Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
    Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019.
    Tofighi B; Lekas HM; Williams SZ; Martino D; Blau C; Lewis CF
    J Subst Abuse Treat; 2021 Oct; 129():108372. PubMed ID: 34080543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
    Breslow RM
    J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol.
    Coffman R; Johnson A; Frede S; Pleiman M; Johnson K
    J Am Pharm Assoc (2003); 2022; 62(4S):S35-S40.e1. PubMed ID: 34930681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moving opioid misuse prevention upstream: A pilot study of community pharmacists screening for opioid misuse risk.
    Strand MA; Eukel H; Burck S
    Res Social Adm Pharm; 2019 Aug; 15(8):1032-1036. PubMed ID: 30031696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing opioid medication misuse at point of service in community pharmacy: A study protocol for an interdisciplinary behavioral health trial.
    Cochran G; Shen J; Cox N; Field C; Carlston K; Sengpraseut B; White A; Okifuji A; Jackman C; Haaland B; Ragsdale R; Gordon AJ; Tarter R
    Contemp Clin Trials; 2022 May; 116():106759. PubMed ID: 35417771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of naloxone availability in Georgia community pharmacies.
    Stone RH; Hur S; Young HN
    J Am Pharm Assoc (2003); 2020; 60(2):357-361. PubMed ID: 31866387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation screening in pharmacies using an iPhone ECG: a qualitative review of implementation.
    Lowres N; Krass I; Neubeck L; Redfern J; McLachlan AJ; Bennett AA; Freedman SB
    Int J Clin Pharm; 2015 Dec; 37(6):1111-20. PubMed ID: 26202627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid risk stratification in the community pharmacy: The utility of the Opioid Risk Tool.
    Strand MA; Eukel HN; Frenzel O; Skoy E; Steig J; Werremeyer A
    Res Social Adm Pharm; 2022 Dec; 18(12):4065-4071. PubMed ID: 35941069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Consumer satisfaction with opioid treatment services at community pharmacies in Australia.
    Lea T; Sheridan J; Winstock A
    Pharm World Sci; 2008 Dec; 30(6):940-6. PubMed ID: 18850299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and acceptability of a proposed pharmacy-based harm reduction intervention to reduce opioid overdose, HIV and hepatitis C.
    Meyerson BE; Agley JD; Jayawardene W; Eldridge LA; Arora P; Smith C; Vadiei N; Kennedy A; Moehling T;
    Res Social Adm Pharm; 2020 May; 16(5):699-709. PubMed ID: 31611071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of patients' demand for community pharmacies: relationship between pharmacy services and patient satisfaction.
    Kamei M; Teshima K; Fukushima N; Nakamura T
    Yakugaku Zasshi; 2001 Mar; 121(3):215-20. PubMed ID: 11265116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Implementation of Tech-Check-Tech Programs in North Dakota Pharmacies.
    Halvorson D; Eukel HN; Gilbraith M; Schaper T; Miller DR
    J Pharm Pract; 2023 Oct; 36(5):1102-1107. PubMed ID: 35417659
    [No Abstract]   [Full Text] [Related]  

  • 40. Community pharmacies as access points for addiction treatment.
    Look KA; Kile M; Morgan K; Roberts A
    Res Social Adm Pharm; 2019 Apr; 15(4):404-409. PubMed ID: 29909934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.